Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

被引:142
作者
Lang, Karl S.
Georgiev, Panco
Recher, Mike
Navarini, Alexander A.
Bergthaler, Andreas
Heikenwalder, Mathias
Harris, Nicola L.
Junt, Tobias
Odermatt, Bernhard
Clavien, Pierre-Alain
Pircher, Hanspeter
Akira, Shizuo
Hengartner, Hans
Zinkernagel, Rolf M.
机构
[1] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Visceral & Transplantat Surg, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Neuropathol, CH-8091 Zurich, Switzerland
[4] Univ Hosp Freiburg, Dept Immunol, Freiburg, Germany
[5] Osaka Univ, Dept Host Def, Suita, Osaka, Japan
关键词
D O I
10.1172/JCI28349
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The liver is known to be a classical immunoprivileged site with a relatively high resistance against immune responses. Here we demonstrate that highly activated liver-specific effector CD8(+) T cells alone were not sufficient to trigger immune destruction of the liver in mice. Only additional innate immune signals orchestrated by TLR3 provoked liver damage. While TLR3 activation did not directly alter liver-specific CD8(+) T cell function, it induced IFN-alpha and TNF-alpha release. These cytokines generated expression of the chemokine CXCL9 in the liver, thereby enhancing CD8(+) T cell infiltration and liver disease in mice. Thus, nonspecific activation of innate immunity can drastically enhance susceptibility to immune destruction of a solid organ.
引用
收藏
页码:2456 / 2463
页数:8
相关论文
共 38 条
[1]   A YOUNG WOMAN WITH HEPATITIS AFTER A SORE THROAT [J].
ACETI, A ;
MURA, MS ;
BABUDIERI, S ;
BACCIU, SA .
LANCET, 1995, 346 (8990) :1603-1603
[2]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[3]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[4]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[5]   Regulatory T cell-mediated transplantation tolerance [J].
Bharat, Ankit ;
Fields, Ryan Courtney ;
Mohanakumar, T. .
IMMUNOLOGIC RESEARCH, 2005, 33 (03) :195-212
[6]   TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs [J].
Bisikirska, B ;
Colgan, J ;
Luban, J ;
Bluestone, JA ;
Herold, KC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2904-2913
[7]   Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells [J].
Bumgardner, GL ;
Orosz, CG .
IMMUNOLOGICAL REVIEWS, 2000, 174 :260-279
[8]   Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway [J].
Chen, M ;
Tabaczewski, P ;
Truscott, SM ;
Van Kaer, L ;
Stroynowski, I .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :1047-1055
[9]   Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis [J].
Cookson, S ;
Constantini, PK ;
Clare, M ;
Underhill, JA ;
Bernal, W ;
Czaja, AJ ;
Donaldson, PT .
HEPATOLOGY, 1999, 30 (04) :851-856
[10]   Interferon-α as a mediator of polyinosinic:polycytidylic acid-induced type 1 diabetes [J].
Devendra, D ;
Jasinski, J ;
Melanitou, E ;
Nakayama, M ;
Li, M ;
Hensley, B ;
Paronen, J ;
Moriyama, H ;
Miao, DM ;
Eisenbarth, GS ;
Liu, E .
DIABETES, 2005, 54 (09) :2549-2556